Approaching clinical application of xenotransplantation

Journal of Cardiac Surgery

Volumn 12, Issue 5, 1997, Pages 285-293

  Platt, Jeffrey L ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; DONOR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IMMUNOPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SPECIES DIFFERENCE; SWINE; UNITED STATES; XENOTRANSPLANTATION; ZOONOSIS;

EID: 0031400066     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1997.tb00141.x     Document Type: Review

References (59)

1. Evans RW, Orians CE, Ascher NL: The potential supply of organ donors: An assessment of the efficiency of organ procurement efforts in the United States. JAMA 1992;267:239-246.
2. Cooper DKC, Kemp E, Platt JL, et al: Xenotransplantation, second edition. Berlin, Springer-Verlag, 1997.
3. Lin SS, Platt JL: Immunologic barriers to xenotransplantation. J Heart Lung Transplant 1996; 15:547-555.
4. Platt JL: Xenotransplantation: Recent progress and current perspective. Curr Opin Immunol 1996;8:721-728.
5. Platt JL, Fischel RJ, Matas AJ, et al: Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52:214-220.
6. Platt, JL: Hyperacute Xenograft Rejection. New York, Springer-Verlag, 1995.
7. Calne RY: Organ transplantation beween widely disparate species. Transplant Proc 1970;2:550-556.
8. Parker W, Yu PB, Holzknecht ZE, et al: Specificity and function of natural antibodies in immunodeficient subjects: Clues to B-cell lineage and development. J Clin Immunol 1997;17:311-321.
9. Galili U, Clark MR, Shohet SB, et al: Evolutionary relationship between the natural anti-Gal antibody and the Gal a1-3Gal epitope in primates. Proc Natl Acad Sci U S A 1987;84:1369-1373.
10. Good AH, Cooper DKC, Malcolm AJ, et al: Identification of carbohydrate structures that bind human antiporcine antibodies: Implications for discordant xenografting in humans. Transplant Proc 1992;24:559-562.
11. Dalmasso AP, Vercellotti GM, Fischel RJ, et al: Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992;140:1157-1166.
12. Platt JL, Vercellotti GM, Dalmasso AP, et al: Transplantation of discordant xenografts: A review of progress. Immunol Today 1990;11:450-456.
13. Fischel RJ, Matas AJ, Platt JL, et al: Cardiac xenografting in the pig to rhesus model; manipulation of anti-endothelial antibody prolongs survival. J Heart Lung Transplant 1992;11:965-974.
14. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transpl 1988;7:238-246.
15. Leventhal JR, Dalmasso AP, Cromwell JW, et al: Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993;55: 857-866.
16. Sachs DH, Sablinski T: Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995;2:234-239.
17. Lin SS, Kooyman DL, Daniels LJ, et al: The role of natural anti-Galα1-3Gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplants. Transpl Immunol 1997;5:212-218.
18. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogeneic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995;1:1261-1267.
19. Sharma A, Okabe JF, Birch P, et al: Reduction in the level of gal (a1,3) gal in transgenic mice and pigs by the expression of an a(1,2) fucosyltransferase. Proc Natl Acad Sci U S A 1996;93:7190-7195.
20. Pruitt SK, Kirk AD, Bollinger RR, et al: The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994;57:363-370.
21. Cotterell AH, Collins BH, Parker W, et al: The humoral immune response in humans following cross-perfusion of porcine organs. Transplantation 1995;60:861-868.
22. Hourcade D, Holers VM, Atkinson JP: The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989;45:381-416.
23. Dalmasso AP, Vercellotti GM, Platt JL, et al: Inhibition of complement-mediated endothelial cell cytotoxicity by decay accelerating factor: Potential for prevention of xenograft hyperacute rejection. Transplantation 1991;52:530-533.
24. White D, Wallwork J: Xenografting: Probability, possibility, or pipe dream? Lancet 1993;342: 879-880.
25. McCurry KR, Kooyman DL, Alvarado CG, et al: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995;1:423-427.
26. Byrne GW, McCurry KR, Martin MJ, et al: Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997;63:149-155.
27. Cozzi E, Yannoutsos N, Langford GA, et al: Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In Cooper DKC, Kemp E, Platt JL (eds): Xenotransplantation: The Transplantation of Organs and Tissues Between Species. Berlin, Springer-Verlag, 1997, pp. 665-682.
28. Leventhal JR, Matas AJ, Sun LH, et al: The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation 1993;56:1-8.
29. Porter KA: Renal Transplantation. In Heptinstall RH (ed): Pathology of the Kidney, Volume III. Boston, MA, Little, Brown, and Company, 1992 pp. 1799-1933.
30. Nagayasu T, Platt JL. Progress in xenotransplantation. Graft 1998;1:19-24.
31. Saadi S, Holzkhecht RA, Patte CP, et al: Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995;182:1807-1814.
32. Holzknecht ZE, Platt JL: Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive antibodies. J Immunol 1995;154:4565-4575.
33. Saadi S, Ihrcke NS, Platt JL: Pathophysiology of xenograft rejection. In Lieberman R, Morris R (eds): Principles of Immunomodulatory Drug Development in Transplantation and Autoimmunity. New York, Raven Press, 1996, pp. 31-45.
34. Lin SS, Weidner BC, Lawson JH, et al: Xenoreactive antibodies in the pathogenesis of acute vascular xenograft rejection in pig-to-primate xenografts. J Clin Invest, in press.
35. McCurry KR, Parker W, Cotterell AH, et al: Humoral responses in pig-to-baboon cardiac transplantation: Implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 1997;58:91-105.
36. Robson SC, Young VK, Cook NS, et al: Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. Transplantation 1996;61:862-868.
37. Bach FH, Ferran C, Hechenleitner P, et al: Accommodation of vascularized xenografts: Expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997;3:196-204.
38. Zehr KJ, Herskowitz A, Lee PC, et al: Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 1994;57:900-906.
39. Chopek MW, Simmons RL, Platt JL: ABO incompatible renal transplantation: Initial immunopathologic evaluation. Transplant Proc 1987;19: 4553-4557.
40. Moses RD, Winn HJ, Auchincloss H Jr: Multiple defects in cell surface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses. Transplantation 1992;53:203-209.
41. Pierson RN, Winn HJ, Russell PS, et al: Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med 1989;170:991-996.
42. Platt JL: Antibodies in graft rejection. In Bach FH, Auchincloss H (eds): Transplantation Immunology. New York, Wiley-Liss, Inc., 1995, pp. 113-129.
43. Ihrcke NS, Wrenshall LE, Lindman BJ, et al: Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today 1993;14: 500-505.
44. Wrenshall LE, Cerra FB, Carlson A, et al: Regulation of T lymphocyte responses by heparan sulfate. J Immunol 1991;147:455-459.
45. Wrenshall LE, Cerra FB, Singh RK, et al. Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes. J Immunol 1995;154:871-880.
46. Yamada K, Sachs DH, DerSimonian H: Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995;155:5249-5256.
47. Murray AG, Khodadoust MM, Pober JS, et al: Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994;1:57-63.
48. Zhao Y, Swenson K, Sergio JJ, et al: Skin graft tolerance across a discordant xenogeneic barrier. Nat Med 1996;2:1211-1216.
49. Li H, Ricordi C, Demetris AJ, et al: Mixed xenogeneic chimerism (mouse + rat - > mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts. Transplantation 1994;57:592-598.
50. Starzl TE, Demetris AJ, Murase N, et al: Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
51. Inverardi L, Samaja M, Motterlini R, et al: Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992;149:1416-1423.
52. Malyguine AM, Saadi S, Holzknecht RA, et al: Induction of procoagulant function in porcine endothelial cells by human NK cells. J Immunol 1997;159:4659-4664
53. Akhter SA, Skaer CA, Kypson AP, et al: Restoration of b-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A 1997;94:12100-12105.
54. Kypson AP, Peppel P, Akhter SA, et al: Ex vivo adenoviral-mediated gene transfer to the transplanted adult rat heart. J Thor Cardiovas Surg 1997;in press.
55. Patience C, Takeuchi Y, Weiss RA: Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-286.
56. Groth CG, Korsgren O, Tibell A, et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994;344:1402-1404.
57. Chari RS, Collins BH, Magee JC, et al: Treatment of hepatic failure with ex-vivo pig liver perfusion followed by liver transplantation. N Engl J Med 1994;331:234-237.
58. Isacson O, Deacon TW, Pakzaban P, et al: Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibers. Nat Med 1995;1:1189-1194.
59. Deacon T, Schumacher J, Dinsmore J, et al: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997;3:350-353.